top of page


ReLink/LinkUS has entered U.S. clinical trials.
Exciting News! ReLink has entered U.S. clinical trials, rebranded as LinkUS. This milestone is a testament to our commitment to...
Sep 14, 2023


Proud Moment for Tada Group AB: Patent Approval in Mexico
We've done it again! ReLink has secured its patent in Mexico. The photo captures the team celebrating this fantastic news. Let’s maintain...
Aug 31, 2023


Patent update: This time it is Malaysia
As we return from summer, our journey of global innovation continues! We're delighted to share that our ReLink technology has secured a...
Aug 17, 2023


ReLink Reaches Patients: A Landmark Achievement in Healthcare Innovation
ReLink Reaches Patients: A Landmark Achievement in Healthcare Innovation
Jul 13, 2023


Tada Group at the EBAN Congress: A Resounding Success!
Tada Group at the EBAN Congress: A Resounding Success!
May 17, 2023


Pure joy! We are turning 7!
Tada Group AB, a leading healthcare company, is thrilled to commemorate an exceptional seven years of dedication, accomplishments, and...
May 16, 2023


Tada Group Attends Hazardous Drugs Best Practice Nursing Conference in London
Tada Group Attends Hazardous Drugs Best Practice Nursing Conference in London
Apr 20, 2023


Tada Group Celebrates 50 Years of the Infusion Nurses Society (INS)
Tada Group Celebrates 50 Years of the Infusion Nurses Society (INS)
Apr 4, 2023


Tada Group Advances Toward FDA Compliance with NAMSA Cours
Tada Group Advances Toward FDA Compliance with NAMSA Course
Mar 3, 2023


Katarina Hedbeck Reflects on an Inspiring LSI USA Event
Katarina Hedbeck Reflects on an Inspiring LSI USA Event
Feb 24, 2023


Patent update: This time it is South Korea
We are thrilled to announce that Tada Group has obtained patent approval for our groundbreaking ReLink safety connector in South Korea....
Dec 20, 2022


Tada Group: Expanding Horizons and Introducing New Company Name
Tada Group, a leading medical device company, is excited to announce its expansion and the introduction of a new company name....
May 15, 2022
bottom of page
